Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP661175.RAuhne9yaiUSuCGRftOFk8GBDa0JY4j_yOOd70W4VuF_8130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661175.RAuhne9yaiUSuCGRftOFk8GBDa0JY4j_yOOd70W4VuF_8130_provenance.
• NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219900.RA5mds4iPuGrUxbkE4Ffy4eYZZ23_6GbcxqMVNVV45nrU130_provenance.
• NP170672.RAVlHC3FTpciS8B5u_EN4zF1HFO7WhufeGwmY_r2EsTXM130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170672.RAVlHC3FTpciS8B5u_EN4zF1HFO7WhufeGwmY_r2EsTXM130_provenance.
• NP392957.RACoR2mWY7o7UqcdeV25Jeh0cHUvKOUzZPs2gnYmmmhS0130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392957.RACoR2mWY7o7UqcdeV25Jeh0cHUvKOUzZPs2gnYmmmhS0130_provenance.
• NP785742.RAvT5fJW1sgkGtKH8JPx98r76ObxbMzsg2YcP3PhUf1vk130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785742.RAvT5fJW1sgkGtKH8JPx98r76ObxbMzsg2YcP3PhUf1vk130_provenance.
• NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
• NP275426.RAWBkRSjtukUbgJ01pI2ZOtaRLCAGUhmZ_o1hC0a2Bu18130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275426.RAWBkRSjtukUbgJ01pI2ZOtaRLCAGUhmZ_o1hC0a2Bu18130_provenance.
• NP275429.RAsAZCMRcgBkNlYTR9Ke_U7NR0TIocVUOcNHUmidf1i7k130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275429.RAsAZCMRcgBkNlYTR9Ke_U7NR0TIocVUOcNHUmidf1i7k130_provenance.
• NP275428.RAFvL1Sg3Scb9DI8NYu0tx3GsSyxKLufQqCEcz9DzG-40130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275428.RAFvL1Sg3Scb9DI8NYu0tx3GsSyxKLufQqCEcz9DzG-40130_provenance.
• NP275427.RAwZSbFuMrnEt3bcy3poik2dd3oIeXqkg69Ok0nkIbd-c130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275427.RAwZSbFuMrnEt3bcy3poik2dd3oIeXqkg69Ok0nkIbd-c130_provenance.